Publication | Closed Access
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
13
Citations
12
References
2021
Year
Effective OptionGastroenterologyClinical GastroenterologySurgeryUlcerative ColitisMedicinePostoperative Recurrence
| Year | Citations | |
|---|---|---|
Page 1
Page 1